<DOC>
	<DOCNO>NCT01612325</DOCNO>
	<brief_summary>Radioembolisation know method treatment liver tumor livermetastases . Currently small beadlets call microspheres use loaded beta radiation emit Yttrium-90 . Holmium-166 microspheres different physical characteristic include good visualisation gammacameras due gamma emission . Because high specific activity high radiation dose liver use compare standard Yttrium treatment . It hypothesize high dos irradiation improve antitumor effect .</brief_summary>
	<brief_title>Radioactive Holmium Microspheres Treatment Unresectable Liver Metastases</brief_title>
	<detailed_description />
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>List inclusion criterion : 1 . Patients must give write informed consent . 2 . Female male age 18 year . 3 . Diagnosis metastatic malignancy liver detectable malignant disease outside liver diagnosis metastatic malignancy liver limited disease outside liver ( i.e . liverdominant disease ) define sum diameter metastases liver 200 % sum diameter soft tissue lesion outside liver . 4 . Patient amenable standard therapy ( radioembolisation ) patient refuse standard therapy reason toxicity 5 . Life expectancy 12 week longer . 6 . World Health Organisation ( WHO ) Performance status 02 ( see Appendix III ) . List exclusion criterion : 1 . Brain metastasis spinal cord compression , unless irradiate least 4 week prior date experimental treatment stable without steroid treatment least 1 week . 2 . Radiation therapy within last 4 week start study therapy . 3 . The last dose prior chemotherapy receive less 4 week prior start study therapy . 4 . Major surgery within 4 week , incompletely heal surgical incision start study therapy . 5 . Any unresolved toxicity great National Cancer Institute ( NCI ) , Common Terminology Criteria Adverse Events ( CTCAE version 4.0 , see Appendix II ) grade 2 previous anticancer therapy . 6 . Serum bilirubin &gt; 1.5 x Upper Limit Normal ( ULN ) . 7 . Glomerular filtration rate &lt; 35 ml/min , determine accord Modification Diet Renal Disease formula . 8 . Alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) , alkaline phosphatase ( ALP ) &gt; 5 x ULN . 9 . Leukocytes &lt; 4.0 109/l and/or platelet count &lt; 150 109/l . 10 . Significant cardiac event ( e.g . myocardial infarction , superior vena cava ( SVC ) syndrome , New York Heart Association ( NYHA ) classification heart disease â‰¥2 within 3 month entry , presence cardiac disease opinion Investigator increase risk ventricular arrhythmia . 11 . Pregnancy breast feeding ( woman childbearing potential ) . 12 . Patients suffer disease increase chance liver toxicity , primary biliary cirrhosis xeroderma pigmentosum . 13 . Patients suffer psychic disorder make comprehensive judgement impossible , psychosis , hallucination and/or depression . 14 . Patients declare incompetent . 15 . Previous enrolment present study previous treatment radioembolisation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>liver tumor</keyword>
</DOC>